Showing results (501-510 of 628) with videos related to
Sort By:
Pageof 63
Bioorganic & Medicinal Chemistry Letters|April 16, 2008
Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurinesRoger J Gillespie, Ian A Cliffe, Claire E Dawson, et al.Bone Marrow Transplantation|November 21, 2012
IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHDL M Pratt, Y Liu, A Ugarte-Torres, et al.Clinical and Laboratory Haematology|January 1, 1983
Bone marrow transplantation for severe aplastic anaemia. A review of the Westminster experience of 24 casesJ R Kendra, C F Lucas, D Chambers, et al.American Journal of Preventive Medicine|October 18, 2016
Alcohol Electronic Screening and Brief Intervention: A Community Guide Systematic ReviewKristin A Tansil, Marissa B Esser, Paramjit Sandhu, et al.Science Advances|June 5, 2020
The genetic architecture of a host shift: An adaptive walk protected an aphid and its endosymbiont from plant chemical defensesKumar Saurabh Singh, Bartlomiej J Troczka, Ana Duarte, et al.Plos Genetics|February 5, 2019
Genomic insights into neonicotinoid sensitivity in the solitary bee Osmia bicornisKatherine Beadle, Kumar Saurabh Singh, Bartlomiej J Troczka, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2008
Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivativesRoger J Gillespie, Ian A Cliffe, Claire E Dawson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2014
Immune cell subset counts associated with graft-versus-host diseasePeter J Podgorny, Yiping Liu, Poonam Dharmani-Khan, et al.Bioorganic & Medicinal Chemistry|August 22, 2009
Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamidesRoger J Gillespie, Samantha J Bamford, Alex Clay, et al.Journal of Medicinal Chemistry|June 29, 2021
Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic SurrogateDouglas S Williamson, Garrick P Smith, Gitte K Mikkelsen, et al.Pageof 63